In Section A, contributors will obtain various doses and schedules of oral ABBV-744 pill to detect Harmless dosing regimen. More contributors might be enrolled in the recognized monotherapy dosign routine. In Segment B, individuals will get oral ruxolitinib and ABBV-744 are going to be provided as "insert-on" therapy. In Phase https://trevorqcnyj.bloggadores.com/31319539/about-abbv-744-in-clinical-trials-for-non-small-cell-lung-cancer-nsclc